Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1465-542X
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer ; volume:21 ; number:1 ; day:5 ; month:7 ; year:2019 ; pages:1-16 ; date:12.2019
Breast cancer research ; 21, Heft 1 (5.7.2019), 1-16, 12.2019

Creator
Palomeras, Sònia
Diaz-Lagares, Ángel
Viñas, Gemma
Setien, Fernando
Ferreira, Humberto J.
Oliveras, Glòria
Crujeiras, Ana B.
Hernández, Alejandro
Lum, David H.
Welm, Alana L.
Esteller, Manel
Puig, Teresa
Contributor
SpringerLink (Online service)

DOI
10.1186/s13058-019-1160-x
URN
urn:nbn:de:101:1-2019121106074221330768
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 6:10 PM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Palomeras, Sònia
  • Diaz-Lagares, Ángel
  • Viñas, Gemma
  • Setien, Fernando
  • Ferreira, Humberto J.
  • Oliveras, Glòria
  • Crujeiras, Ana B.
  • Hernández, Alejandro
  • Lum, David H.
  • Welm, Alana L.
  • Esteller, Manel
  • Puig, Teresa
  • SpringerLink (Online service)

Other Objects (12)

Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer

Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer

Epigenetic silencing of SALL 2 confers tamoxifen resistance in breast cancer

Epigenetic silencing of SALL 2 confers tamoxifen resistance in breast cancer

CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer

CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer

Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R

Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R

Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer

Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer

Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation

Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation

RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1

RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1

Epigenetic silencing of MEIS2 in prostate cancer recurrence

Epigenetic silencing of MEIS2 in prostate cancer recurrence

Epigenetic silencing of serine protease HTRA1 drives polyploidy

Epigenetic silencing of serine protease HTRA1 drives polyploidy

Clusterin confers gmcitabine resistance in pancreatic cancer

Clusterin confers gmcitabine resistance in pancreatic cancer

LMTK3 confers chemo-resistance in breast cancer

LMTK3 confers chemo-resistance in breast cancer

YAP represses intestinal inflammation through epigenetic silencing of JMJD3

YAP represses intestinal inflammation through epigenetic silencing of JMJD3

Related objects